Fluorescent Particles Based on Aggregation-Induced Emission for Optical Diagnostics of the Central Nervous System

Overview

Journal Research (Wash D C)

Date 2025 Jan 27

PMID 39866911

Authors

Shan Liu

Jinkuan Liu

Xue Li

Xiaoxin Du

Cheng Yin

Yong Luo

Chenzhong Li

Affiliations

Soon will be listed here.

Abstract

In 2001, Tang's team discovered a unique type of luminogens with substantial enhanced fluorescence upon aggregation and introduced the concept of "aggregation-induced emission (AIE)". Unlike conventional fluorescent materials, AIE luminogens (AIEgens) emit weak or no fluorescence in solution but become highly fluorescent in aggregated or solid states, due to a mechanism known as restriction of intramolecular motions (RIM). Initially considered a purely inorganic chemical phenomenon, AIE was later applied in biomedicine to improve the sensitivity of immunoassays. Subsequently, AIE has been extensively explored in various biomedical applications, especially in cell imaging. Early studies achieved nonspecific cell imaging using nontargeted AIEgens, and later, specific cellular imaging was realized through the design of targeted AIEgens. These advancements have enabled the visualization of various biomacromolecules and intracellular organelles, providing valuable insights into cellular microenvironments and statuses. Neurological disorders affect over 3 billion people worldwide, highlighting the urgent need for advanced diagnostic and therapeutic tools. AIEgens offer promising opportunities for imaging the central nervous system (CNS), including nerve cells, neural tissues, and blood vessels. This review focuses on the application of AIEgens in CNS imaging, exploring their roles in the diagnosis of various neurological diseases. We will discuss the evolution and conclude with an outlook on the future challenges and opportunities for AIEgens in clinical diagnostics and therapeutics of CNS disorders.

References

Griffith J, Sarkaria J, Elmquist W . Efflux Limits Tumor Drug Delivery Despite Disrupted BBB. Trends Pharmacol Sci. 2021; 42(6):426-428. DOI: 10.1016/j.tips.2021.03.001. View

Gitler A, Dhillon P, Shorter J . Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech. 2017; 10(5):499-502. PMC: 5451177. DOI: 10.1242/dmm.030205. View

Dugger B, Dickson D . Pathology of Neurodegenerative Diseases. Cold Spring Harb Perspect Biol. 2017; 9(7). PMC: 5495060. DOI: 10.1101/cshperspect.a028035. View

Yuan Y, Zhang Z, Hou W, Qin W, Meng Z, Wu C . In vivo dynamic cell tracking with long-wavelength excitable and near-infrared fluorescent polymer dots. Biomaterials. 2020; 254:120139. DOI: 10.1016/j.biomaterials.2020.120139. View

Hong Y, Meng L, Chen S, Leung C, Da L, Faisal M . Monitoring and inhibition of insulin fibrillation by a small organic fluorogen with aggregation-induced emission characteristics. J Am Chem Soc. 2011; 134(3):1680-9. DOI: 10.1021/ja208720a. View

Kuznetsova I, Sulatskaya A, Uversky V, Turoverov K . Analyzing thioflavin T binding to amyloid fibrils by an equilibrium microdialysis-based technique. PLoS One. 2012; 7(2):e30724. PMC: 3286464. DOI: 10.1371/journal.pone.0030724. View

Ma X, Liu L, Meng J . MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer's disease. Neurosci Lett. 2017; 661:57-62. DOI: 10.1016/j.neulet.2017.09.043. View

Ladomersky E, Scholtens D, Kocherginsky M, Hibler E, Bartom E, Otto-Meyer S . The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma. Front Pharmacol. 2019; 10:200. PMC: 6446059. DOI: 10.3389/fphar.2019.00200. View

Sarkar B, Mithu V, Chandra B, Mandal A, Chandrakesan M, Bhowmik D . Significant structural differences between transient amyloid-β oligomers and less-toxic fibrils in regions known to harbor familial Alzheimer's mutations. Angew Chem Int Ed Engl. 2014; 53(27):6888-92. DOI: 10.1002/anie.201402636. View

10.

Xu L, Sun L, Zeng F, Wu S . Activatable fluorescent probe based on aggregation-induced emission for detecting hypoxia-related pathological conditions. Anal Chim Acta. 2020; 1125:152-161. DOI: 10.1016/j.aca.2020.05.046. View

11.

Kim W, Bonoiu A, Hayakawa T, Xia C, Kakimoto M, Pudavar H . Hyperbranched polysiloxysilane nanoparticles: surface charge control of nonviral gene delivery vectors and nanoprobes. Int J Pharm. 2009; 376(1-2):141-52. DOI: 10.1016/j.ijpharm.2009.04.023. View

12.

Fu W, Yan C, Guo Z, Zhang J, Zhang H, Tian H . Rational Design of Near-Infrared Aggregation-Induced-Emission-Active Probes: In Situ Mapping of Amyloid-β Plaques with Ultrasensitivity and High-Fidelity. J Am Chem Soc. 2019; 141(7):3171-3177. DOI: 10.1021/jacs.8b12820. View

13.

Gundemir S, Monteagudo A, Akbar A, Keillor J, Johnson G . The complex role of transglutaminase 2 in glioblastoma proliferation. Neuro Oncol. 2016; 19(2):208-218. PMC: 5464277. DOI: 10.1093/neuonc/now157. View

14.

Wang Y, Chen M, Alifu N, Li S, Qin W, Qin A . Aggregation-Induced Emission Luminogen with Deep-Red Emission for Through-Skull Three-Photon Fluorescence Imaging of Mouse. ACS Nano. 2017; 11(10):10452-10461. DOI: 10.1021/acsnano.7b05645. View

15.

Ding F, Feng J, Zhang X, Sun J, Fan C, Ge Z . Responsive optical probes for deep-tissue imaging: Photoacoustics and second near-infrared fluorescence. Adv Drug Deliv Rev. 2021; 173:141-163. DOI: 10.1016/j.addr.2021.03.008. View

16.

Larson D, Zipfel W, Williams R, Clark S, Bruchez M, Wise F . Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science. 2003; 300(5624):1434-6. DOI: 10.1126/science.1083780. View

17.

Robinson J, Tabakman S, Liang Y, Wang H, Sanchez Casalongue H, Vinh D . Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc. 2011; 133(17):6825-31. DOI: 10.1021/ja2010175. View

18.

Malekjani N, Jafari S . Modeling the release of food bioactive ingredients from carriers/nanocarriers by the empirical, semiempirical, and mechanistic models. Compr Rev Food Sci Food Saf. 2021; 20(1):3-47. DOI: 10.1111/1541-4337.12660. View

19.

Cai X, Bandla A, Mao D, Feng G, Qin W, Liao L . Biocompatible Red Fluorescent Organic Nanoparticles with Tunable Size and Aggregation-Induced Emission for Evaluation of Blood-Brain Barrier Damage. Adv Mater. 2016; 28(39):8760-8765. DOI: 10.1002/adma.201601191. View

20.

Kawaguchi T, Sonoda Y, Shibahara I, Saito R, Kanamori M, Kumabe T . Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion. J Neurooncol. 2016; 129(3):505-514. DOI: 10.1007/s11060-016-2201-2. View